From 2021, pharmacies will no longer reimburse these drugs amoxicillin and Fenghan cold particles...

Medicine Network October 22 - From January 1, 2021, pharmacies a large number of pharmaceutical medical insurance is no longer reimbursed, mainly for the provinces to supplement the catalog varieties and national key monitoring drugs, both Western medicine, but also involved in traditional Chinese medicine, including amoxicine, wind cold particles, anti-sensing particles, gold and silver flower oral solution and a number of common drugs.
Since 2021, a large number of varieties have been transferred out of Shaanxi Province: 63 kinds of drugs transferred out of health insurance according to the Shaanxi Medical Insurance Bureau previously issued "on the transfer of some drugs out of Shaanxi Province basic medical insurance, work injury insurance and maternity insurance payment scope notice", in accordance with the relevant requirements of the State Health Insurance Bureau, gradually digest the original provincial drug catalogue in accordance with the provisions of the addition of Class B drugs, after experts demonstrated and publicity, decided to transfer some drugs out of Shaanxi Province basic medical insurance, industrial injury insurance and maternity insurance payment scope.
As of January 1, 2021, 63 kinds of drugs, such as aluminum hydroxide gel, Mosabili oral liquid agent, metformin marazine roglitazone regular release dosage form, amoxicillin oral regular release dosage form, etc., will be transferred out of Shaanxi Province basic medical insurance, work injury insurance and maternity insurance payment range.
will also guide the designated medical institutions to notify the timely replacement of therapeutic drugs, to ensure the smooth implementation as scheduled.
Qinghai Province: 227 additional drugs out of the province out of health insurance October 10, Qinghai Medical Insurance Bureau issued "on the issuance of Qinghai Province's additional drug digestion directory notice" said that, in accordance with the relevant requirements of the medical insurance issued (2019) Document No. 46, after study, decided to add 227 drugs to Qinghai Province, Qinghai Province basic medical insurance, work injury insurance and maternity insurance drug catalog (2019 edition).
in addition, in 2020, Qinghai Province will transfer the state's key monitoring drugs and the previous year's Qinghai Province drug procurement platform for the use of drugs, a total of 129 varieties, from January 1, 2021 to stop medical insurance, work injury insurance payment.
Henan Province: 320 drugs transferred out of health insurance According to industry news, Henan hospital health insurance office will be the Henan Provincial Health Insurance Bureau recently announced the transfer out of the list of medical insurance list of drugs to all departments, including 180 Western medicine and 140 Chinese medicine, Involved in Azac Joan injections, qumeibutin oral liquid agent, bival reed injections and other Western medicines, as well as cold cold particles, anti-sensing particles, gold and silver flower oral liquid and other well-known Chinese medicine, a total of 320 drugs.
According to the notice of the Henan Provincial Medical Insurance Bureau, all drugs not included in the medical insurance catalogue of Henan Province will be transferred out in one go (except ethnic medicines) and the National List of Essential Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drugs will be implemented in a unified implementation from January 1, 2021 (2019 edition).
the co-ordination areas shall not make their own catalogues or increase the number of drugs in the catalogues by changing methods, and shall not adjust the drugs in the catalogues themselves and limit the scope of payment.
Chongqing City: the first year of digestion of drugs will stop medical insurance reimbursement in June this year, Chongqing Municipal Health Insurance Bureau issued "on chongqing City gradually digest the local supplement of the list of health insurance Class B drugs", clearly the first year of digestion of drugs, from January 1, 2021 to stop medical insurance reimbursement.
The main drugs digested in the first year are: drugs with the approval number "Drug Code B", drugs that have been included in the medical insurance catalogue but the manufacturer has not applied for medical insurance reimbursement, and medicines that do not have purchasing data at the Drug Exchange in 2019.
Where to add catalog varieties out of health insurance, many implementation so far, including Gansu, Ningxia, Xinjiang, Guangxi, Zhejiang, Shaanxi, a total of more than 20 provinces landed to implement the local supplement directory transfer policy - of which Yunnan, Hunan, Jilin, Tianjin, Hebei, Anhui Tibet and other places have made clear the first batch of additional varieties of local health insurance, a large number of varieties from July 1, 2020 out of the local health insurance directory;
some provinces and cities have eliminated varieties of Beijing: from October 1, 224 kinds of drugs will no longer be reimbursed by the Beijing Municipal Health Insurance Bureau and the Municipal Bureau of Human Resources and Social Security recently jointly issued a notice, clearly from October 1, 2020, benzodiaphenicol and other 224 kinds of non-national medical insurance drug catalog varieties from the city's medical insurance drug catalog.
after the transfer is no longer covered by the city's basic medical insurance, work injury insurance and maternity insurance.
Of the 224 drugs, there are 136 kinds of Western medicine and 88 kinds of traditional Chinese medicine, including some common drugs, such as benzodiazepone for the treatment of diabetes, halomisone for the treatment of skin diseases, antibiotic-type drugs Klinmycin, anti-heat analgesic drug ibuprofen and antivenomic serum injection preparations.
in chinese medicine, there are children's cold hot tablets, cold deheated particles, compound Dansan injections, ten drops of water capsules, hemp intestinal capsules, mulberry cold oral solution and antelope lung dispersal.
Beijing in early 2020 has begun to implement the latest list of medical insurance drugs, the main reason for the transfer of drugs is to implement the "three years to gradually digest the local medical insurance catalogue of non-state medical insurance drug varieties" this unified national requirements.
Beibei: From July 1st, 171 varieties will no longer be reimbursed June 29th, Hebei Provincial Health Insurance Bureau issued "on the 2020 digestion out of Hebei Province's medical insurance drug catalogue temporarily retained additional drugs" said, in order to implement the State Health Insurance Administration on "by the end of June this year to remove the national key monitoring varieties out of the catalog and complete 40% of the province's additional varieties of digestion" deployment requirements, Hebei Province is now proposed to transfer the list of additional drugs.
statistics, Hebei Province announced a total of 171 varieties, these varieties have been transferred out of Hebei Province's health insurance directory from July 1.
, Yunnan: 837 varieties of reimbursement as of the end of June July 1, Yunnan Medical Insurance Bureau issued the "Yunnan Province super-national medical insurance drug catalog scope drug digestion and adjustment program" notice, said that in order to strictly implement the "2019 edition of the National Drug Catalog", from 2020 From 2400 hours on June 30, 2019, the 2019 edition of the National Drug Catalog transferred drugs, drugs beyond the state medical insurance payment dosage form, compound drugs, Chinese medicine tablets that the state expressly does not pay, the state key monitoring drugs to stop medical insurance reimbursement.
statistics, Yunnan Province's super-national medical insurance catalogue of 837 drugs, of which 416 are Western medicine, 421 Chinese medicine.
Chuan: 100 kinds of drugs, from July no longer reimbursed June 23, Sichuan Health Insurance Bureau, the Ministry of Human Resources and Social Security jointly issued a notice to be included in the scope of the state's key monitoring of the conversion of sugar electrolyte injections and other six drugs from July 1, 2020 out of the "Drug Catalog."
addition to the national key monitoring varieties, 94 kinds of drugs, such as domifen tablets, were also transferred out of the "Drug Catalog" on August 1, 2020.
44 drugs, including aluminum magnesium pills (II), will be released from the Drug Catalog on August 1, 2021.
However, in order to ensure the continuity of drug use of the insured persons, after verifying the relevant drug recruitment data, it was decided that the two drugs of compound sodium acetate ring injection and compound Lidokain injection should not be transferred out of the "Sichuan Province Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog (2018 Edition)".
, Guangxi: 186 varieties out of the catalogue On June 4, the Guangxi Zhuang Autonomous Region Medical Insurance Bureau issued a notice on adjusting the regulation of guangxi basic medical insurance, work injury insurance and maternity insurance drug catalogue.
The drugs transferred in accordance with the provisions within the scope of payment of basic medical insurance, work injury insurance and maternity insurance drugs in Guangxi will be gradually digested within three years, and the catalogue of drugs for basic medical insurance, work injury insurance and maternity insurance will be implemented in a unified and unified form from June 1, 2022.
144 drugs have been transferred out of the Western medicine section and 42 drugs have been transferred out of the Chinese medicine section in the adjustment norms implemented since June 1, 2020.
If one of the following five categories exists in accordance with Article 9 of the Interim Measures for the Administration of Drug Use in Basic Medical Insurance, the medical insurance drug catalogue shall be transferred directly from the Medical Insurance Drug Catalog after expert review: 1. The drug that has been revoked, revoked or cancelled by the drug regulatory department; 2, by the relevant departments included in the negative list of drugs; 3, comprehensive consideration of clinical value, adverse reactions, drug economy and other factors, after assessment that the risk is greater than the benefits of drugs; 4, through fraud and other illegal means into the "drug catalog" of drugs; 5, the State provisions should be directly transferred out of other circumstances.
.